ACTOVEGIN® 200 mg – 50 Tablets

Product Description

• Brand Name: ACTOVEGIN®
• Active Substance: Deproteinized Hemoderivative of Calf Blood
• Strength: 200 mg per tablet
• Dosage Form: Coated tablets
• Pack Size: 50 tablets
• Manufacturer: Takeda Pharmaceuticals
• Category: Metabolic and tissue-support therapy

Therapeutic Uses

ACTOVEGIN is used in some countries for:

• Peripheral circulation disorders
• Cerebral circulation and metabolic disturbances
• Diabetic polyneuropathy
• Support of tissue repair and healing
• Conditions associated with impaired oxygen utilization in tissues

Mechanism of Action

ACTOVEGIN contains biologically active compounds derived from calf blood that may:

• Enhance cellular oxygen uptake
• Improve glucose utilization by tissues
• Support cellular energy metabolism
• Promote tissue regeneration and repair

Presentation

• Round coated tablets
• Each tablet contains 200 mg of deproteinized hemoderivative
• Supplied in a box containing 50 tablets

Storage

• Store below the temperature recommended by the manufacturer.
• Protect from moisture and direct sunlight.
• Keep out of reach of children.

Important Information

• ACTOVEGIN is available in certain countries and regions but is not approved in some others.
• Use only under the guidance of a qualified healthcare professional.
• Dosage and treatment duration depend on the medical condition being treated.

Note: Packaging design may vary depending on the market and manufacturing batch. The images above represent typical ACTOVEGIN® 200 mg tablet packaging.